| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/31/2003 | US20030144330 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells |
| 07/31/2003 | US20030144329 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases |
| 07/31/2003 | US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/31/2003 | US20030144327 Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl |
| 07/31/2003 | US20030144326 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 07/31/2003 | US20030144325 For reducing levels of tumor necrosis factor alpha in mammals; for example, 1-oxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafuoroisoindoline |
| 07/31/2003 | US20030144324 Comprising paroxetine hydrochloride anhydrous, povidone, copovidone as binder, and a hydrochloric acid free/non-hygroscopic filler, prepared by wet granulation; antidepressant, anxiety disorders, sexual disorders |
| 07/31/2003 | US20030144323 Phenylalkynes |
| 07/31/2003 | US20030144322 Analogs of cocaine |
| 07/31/2003 | US20030144321 Antitumor agents |
| 07/31/2003 | US20030144318 Methods and compositions for treatment of erectile dysfunction |
| 07/31/2003 | US20030144316 Remedies |
| 07/31/2003 | US20030144313 Non-steroidal, tetracylic compounds for estrogen-related treatments |
| 07/31/2003 | US20030144312 Coadministering a dose of anti-tumor agent and an opioid inhibitor of ATP-binding cassette (ABC) drug transporter protein to increase the concentration of the antitumor agent in the cancer cell; potentiation; crosses blood-brain barrier |
| 07/31/2003 | US20030144311 Propanoic acid derivatives as intergrin receptor antagonists |
| 07/31/2003 | US20030144309 Inhibitors of Src and other protein kinases |
| 07/31/2003 | US20030144306 A liquid oral composition comprising a proton pump inhibitor, e,g, omeprazole, lansoprazole,and a buffer; can also contain a parietal cell activator; acid resistance; side effect reduction; kits; drug delivery; Zollinger-Ellison syndrome |
| 07/31/2003 | US20030144305 Novel compounds |
| 07/31/2003 | US20030144304 Novel hexacyclic compounds |
| 07/31/2003 | US20030144303 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 07/31/2003 | US20030144302 Process for making substituted pyrazoles |
| 07/31/2003 | US20030144301 Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase |
| 07/31/2003 | US20030144300 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 07/31/2003 | US20030144299 Method of treating depression with delta receptor agonist compounds |
| 07/31/2003 | US20030144298 Therapeutic combinations of antihypertensive and antiangiogenics agents |
| 07/31/2003 | US20030144296 Daily treatment for erectile dysfunction using a PDE5 inhibitor |
| 07/31/2003 | US20030144295 A synergistic antiischemic mixture of a tissue plasminogen activator, e.g. alteplase, pamiteplase, and zonampanel(7-imidazol-1-yl-6-nitro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin -1-yl acetic acid for strokes or cerebral infarctions |
| 07/31/2003 | US20030144293 N-alkyl-adamantyl triazinyl benzamide derivatives |
| 07/31/2003 | US20030144292 Protease inhibitors such as N-((4'-Methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl-N-methyl-amino)-(4 -hydroxycyclohexan-1-yl)-acetic acid for prophylaxis of neurodegenerative diseases, vision defects, skin disorders or as antiinflammatory agents |
| 07/31/2003 | US20030144291 Substituted indan derivatives |
| 07/31/2003 | US20030144290 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
| 07/31/2003 | US20030144289 Dopamine and serotonin reuptake antagonists, used for the prophylaxis of drug abuse or dependence, neurodegenerative diseases or as antidepressants |
| 07/31/2003 | US20030144288 Sulfur compounds such as 4-fluoro-N-(4-methoxy-7-(tetrahydro-pyran-4-yl)-benzothiazol-2-yl) -benzamide, used as preferential adenosine receptor ligands for the prophylaxis of neurodegenerative disorders |
| 07/31/2003 | US20030144287 Heterocyclic amides such as N-(4-(2-(((methyl)amino)methyl)-1H-imidazol-1-yl)-2-fluorophenyl)-1-(3-amino-1,2-benzisoxazol-5-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide, used as anticoagulants; prophylaxis of cardiovascular disorders |
| 07/31/2003 | US20030144286 Nitrogen compounds such as 3-nitro-N-(1H-benzoimidazol-2-yl)-benzamide, used as nonsteroidal antiinflammatory agents, immunology or interleukin receptor associated kinase (IRAK) modulators; rheumatic diseases; multiple sclerosis |
| 07/31/2003 | US20030144284 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents |
| 07/31/2003 | US20030144283 Amide substituted imidazoquinolines |
| 07/31/2003 | US20030144281 Substituted benzimidazole compounds |
| 07/31/2003 | US20030144280 Heterocyclic imines, used as cyclooxygenase inhibitors, administered as inflammatory and pain relievers in disorders such as arthritis, neurodegeneration or cancer in mammals |
| 07/31/2003 | US20030144279 5-Heterocyclo-pyrazoles |
| 07/31/2003 | US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 07/31/2003 | US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 07/31/2003 | US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis |
| 07/31/2003 | US20030144272 Heterocyclic amines such as 2-(2-(N-Methylsulfamoyl)-4-methoxy -phenyl)-N-methyl-N-((1S)-1-phenyl-2-((1-pyrrolidinyl)ethyl)) acetamide, administered as analgesics |
| 07/31/2003 | US20030144271 Methods for the treatment of substance abuse |
| 07/31/2003 | US20030144270 Neurokinin receptor antagonists comprising heterocyclic amides used as antiemetics, antidepressants and/or antitussive agents |
| 07/31/2003 | US20030144269 Administering an effective amount of vasopeptidase inhibitor such as omapatrilat or gemopatrilat for reducing hypertension |
| 07/31/2003 | US20030144268 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 07/31/2003 | US20030144267 Novel compounds |
| 07/31/2003 | US20030144266 Pyrazolo-triazolo- pyrimidine, triazolo-triazolo-pyrimidine and imidazolo-triazolo-pyrimidine derivatives useful for the treatment of hypertension, inflammation, mast cell degranulation, cardiac hypoxia, and ischemia |
| 07/31/2003 | US20030144264 Carbapenems containing a carboxy substituted phenyl group and useful for treating bacterial infections in mammals and humans |
| 07/31/2003 | US20030144263 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 07/31/2003 | US20030144262 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes |
| 07/31/2003 | US20030144261 A cyclic peptide useful for treating eating disorder and diabetes |
| 07/31/2003 | US20030144259 Exemestane for use in the first-line treatment of metastatic, advanced hormone-dependent breast cancer, particularly in post-menopausal woman; endorcine therapy |
| 07/31/2003 | US20030144258 Drospirenone for hormone replacement therapy |
| 07/31/2003 | US20030144257 Administering to a human or animal for inflammation/allergies 6-alpha-9-alpha-difluoro-17 alpha-(2-furanylcarbonyl)oxy)-11 beta-hydroxy-16-alpha-methyl-3-oxo-androsta-1,4-diene-17 beta-carbothioic acid-s-fluoromethyl ester |
| 07/31/2003 | US20030144256 Administration of a retinoid or retinoid derivative that is able to act as an antagonist or inverse agonist of a retinoic acid receptor (RAR) for preventing spermatogenesis in a male mammal |
| 07/31/2003 | US20030144255 Compositions for prevention and treatment of dementia |
| 07/31/2003 | US20030144254 Administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of 3 or 7 or 3 and 7 thia-prostanoic acid, ester, amide, phosphonate or other derivatives |
| 07/31/2003 | US20030144253 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 07/31/2003 | US20030144252 Bicalutamide and N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4 -amine used as inhibitor of prostate cancer |
| 07/31/2003 | US20030144250 Triazole derivatives useful in therapy |
| 07/31/2003 | US20030144249 Aminoalkylenephosphoxide derivatives, useful as bactericide, fungicide, viricide and parasiticide |
| 07/31/2003 | US20030144248 Surfactant prevention of lung complications from cancer chemotherapy |
| 07/31/2003 | US20030144246 Chromenylmethyl pyrimidinediamines as antibacterial agents |
| 07/31/2003 | US20030144245 Medical and nutritional applications of highly refined cellulose |
| 07/31/2003 | US20030144244 Stable compositions of S-adenosyl-l-methionine with dextran |
| 07/31/2003 | US20030144243 Combination of a crystalline drug form and atiotropium salt |
| 07/31/2003 | US20030144239 Expression system |
| 07/31/2003 | US20030144234 Administering a cathepsin modulator or enzyme inhibitor, select from a mRNA or a protein; gene expression inhibition, analgesics |
| 07/31/2003 | US20030144233 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 07/31/2003 | US20030144232 Expression system |
| 07/31/2003 | US20030144222 Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof |
| 07/31/2003 | US20030144220 Use of CYP2D6 inhibitors in combination therapies |
| 07/31/2003 | US20030144219 Formulations and methods for treatment or amelioration of inflammatory conditions |
| 07/31/2003 | US20030144217 Prodrugs of aspartyl protease inhibitors |
| 07/31/2003 | US20030144216 Method for prevention of diseases in coeliac patients |
| 07/31/2003 | US20030144215 Methods of treatment and pharmaceutical composition |
| 07/31/2003 | US20030144214 Alkyl amino acid derivatives useful as pharmaceutical agents |
| 07/31/2003 | US20030144213 Combination therapy of angiotensin converting enzyme inhibitor, side-effect reduced amount of aldosterone antagonist and diuretic for treatment of cardiovascular disease |
| 07/31/2003 | US20030144212 Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host |
| 07/31/2003 | US20030144207 Hydrophilic conjugate having a peptide that is capable of passing the blood-brain barrier covalently linked to a water-soluble nonpeptidic polymer |
| 07/31/2003 | US20030144206 Combined use of a GLP-1 compound and modulator of diabetic late complications |
| 07/31/2003 | US20030144203 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/31/2003 | US20030144200 Novel forms of the angiogenic factor vascular endothelial cell growth factor: VEGF |
| 07/31/2003 | US20030144198 Increasing gastrointestinal absorption |
| 07/31/2003 | US20030144194 Cancer treatment and prognosis |
| 07/31/2003 | US20030144178 Administering 4-(4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline or 4-(3'-bromo-4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline |
| 07/31/2003 | US20030144176 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy |
| 07/31/2003 | US20030144175 Protease inhibitors |
| 07/31/2003 | US20030144052 System and method for facilitating play of a game with user-selected elements |
| 07/31/2003 | US20030143713 Novel glycosidase inhibitors and their pharmacological uses, in particular for treating diabetes |
| 07/31/2003 | US20030143676 Receptor polypeptides and polynucleotides encoding such polypeptides; for treating a disorder characterized by an elevated level of osteopontin |
| 07/31/2003 | US20030143667 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 07/31/2003 | US20030143629 Comprises polypeptide semiconductors which relay fluorescent/luminescent signals when binding moieties/analytes; neutralizes anthrax spores in combination with radiation |
| 07/31/2003 | US20030143626 Such as cyclin-dependent kinases and/or bax genes/proteins covalently linked to platform compound (thioredoxin); drug screening |
| 07/31/2003 | US20030143621 Contacting a cellular component with a reagent which binds to PC-1 (prostate cancer-1) protein |
| 07/31/2003 | US20030143620 Carbohydrate ligands specific for MHC molecules |
| 07/31/2003 | US20030143610 Methods for the treatment of metabolic disorders, including obesity and diabetes |